The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Efficient, Long Term Production of Monocyte-Derived Macrophages from Human Pluripotent Stem Cells under Partly-Defined and Fully-Defined Conditions
Open accessAbstract
Human macrophages are specialised hosts for HIV-1, dengue virus, Leishmania and Mycobacterium tuberculosis. Yet macrophage research is hampered by lack of appropriate cell models for modelling infection by these human pathogens, because available myeloid cell lines are, by definition, not terminally differentiated like tissue macrophages. We describe here a method for deriving monocytes and macrophages from human Pluripotent Stem Cells which improves on previously published protocols in that it uses entirely defined, feeder- and serum-free culture conditions and produces very consistent, pure, high yields across both human Embryonic Stem Cell (hESC) and multiple human induced Pluripotent Stem Cell (hiPSC) lines over time periods of up to one year. Cumulatively, up to ∼3×10(7) monocytes can be harvested per 6-well plate. The monocytes produced are most closely similar to the major blood monocyte (CD14(+), CD16(low), CD163(+)). Differentiation with M-CSF produces macrophages that are highly phagocytic, HIV-1-infectable, and upon activation produce a pro-inflammatory cytokine profile similar to blood monocyte-derived macrophages. Macrophages are notoriously hard to genetically manipulate, as they recognise foreign nucleic acids; the lentivector system described here overcomes this, as pluripotent stem cells can be relatively simply genetically manipulated for efficient transgene expression in the differentiated cells, surmounting issues of transgene silencing. Overall, the method we describe here is an efficient, effective, scalable system for the reproducible production and genetic modification of human macrophages, facilitating the interrogation of human macrophage biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, these cells closely match tissue macrophages at both transcriptional and functional levels (184–186).”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [185]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The cumulative yield of pMacpre for the lines used in this study was 10- to 43-fold higher than the number of input iPSCs, consistent with yields previously reported for this protocol (van Wilgenburg et al., 2013), similar to a recently published hiPS-microglia protocol (typically 40-fold) (Abud et al., 2017), and 10-fold higher than two other recently published hiPS-microglia protocols (0.5- to 4”
From A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response (2017) · cites this paper as van Wilgenburg et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“In 2008, we derived human PSC macrophages using a very simple methodology without OP9 feeders (Karlsson et al., 2008), which we subsequently adapted to a fully defined, robust serum-free protocol (van Wilgenburg et al., 2013), now widely used by others (Aflaki et al., 2014, Alasoo et al., 2015, Gupta et al., 2016).”
From A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response (2017) · cites this paper as van Wilgenburg et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY
Reynolds, E. S. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.1.208 · Cited by 24,938
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz‐Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,947
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960
Feeder-free growth of undifferentiated human embryonic stem cells
Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., & Carpenter, M. K. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-971 · Cited by 1,872
The CD14+ CD16+ blood monocytes: their role in infection and inflammation
Ziegler‐Heitbrock, L. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806510 · Cited by 1,045
Flagged first, then by citations
Research works printed but not linked: 1
- K Karlsson, 2008, Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3, Experimental hematology, 36, 1167, 10.1016/j.exphem.2008.04.009 · DOI · Paper page
Cited by
Sorted by citations
Items 201–300 of 360
Smart Cell Therapy: an industry perspective on macrophages as living drugs
Rodgers, D. T., Novobrantseva, T. I., & Bárcia, R. N. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.12.002 · Cited by 7
Optimized Method to Generate Well-Characterized Macrophages from Induced Pluripotent Stem Cells
Hai, Q., Bazeley, P. S., Han, J., Brubaker, G., Powers, J., Diaz-Montero, C. M., & Smith, J. D. (2025) · Biomedicines · doi:10.3390/biomedicines13010099 · Cited by 7
In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
Hall‐Roberts, H., Daniel, E. D., James, W., Davis, J. B., & Cowley, S. A. (2021) · Journal of Visualized Experiments · doi:10.3791/62217 · Cited by 13
Self-citationSchinke, M., Meyer, G., Hashtchin, A. R., Hetzel, M., Abdin, S. M., Wegner, T., Schwarzer, A., Hansen, G., Schambach, A., Lachmann, N., et al. (2022) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2022.100061 · Cited by 7
Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures
Knappe, E., Rudolph, F., Klein, C., & Seibler, P. (2023) · Cells · doi:10.3390/cells12212535 · Cited by 8
The Pluripotent Path to Immunotherapy
Diop, M. P., & van der Stegen, S. J. C. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104648 · Cited by 10
Jung‐Klawitter, S., & Opladen, T. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0225-9 · Cited by 8
Lee, J. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081825 · Cited by 7
Haukedal, H., Lorenzen, S. S., Westi, E. W., Corsi, G. I., Gadekar, V. P., McQuade, A., Davtyan, H., Doncheva, N. T., Schmid, B., Chandrasekaran, A., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.024 · Cited by 7
Chingwaru, W., Glashoff, R. H., Vidmar, J., Kapewangolo, P. T., & Sampson, S. L. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.07.002 · Cited by 7
Dolatshad, H., Tatwavedi, D., Ahmed, D., Tegethoff, J. F., Boultwood, J., & Pellagatti, A. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.10.001 · Cited by 7
An immune cell spray (ICS) formulation allows for the delivery of functional monocyte/macrophages
Beneke, V., Küster, F., Neehus, A., Hesse, C., López-Rodríguez, E., Haake, K., Hashtchin, A. R., Schott, J. W., Walter, D., Braun, A. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34524-2 · Cited by 8
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages
Pickering, S., Wilson, H., Bravo, E., Perera, M. R., Seow, J., Graham, C., Almeida, N., Fotopoulos, L., Williams, T., Moitra, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54458-w · Cited by 6
Liao, F., Calvo-Rodríguez, M., Chhaya, M., Sefrin, J. P., Charych, E. I., Mezler, M., Clausznitzer, D., McGlame, E. J., Zhao, K., Rodgers, A., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02892-5 · Cited by 7
iPSC-derived macrophages: An in vitro model to study human disease-relevant macrophage biology
Sauer, J., Schloesser, D., Koeppen, K., Fundel‐Clemens, K., Simone-Roach, C., Hall, K., Ivovic, A., Makings, J., Reiss, D., Traub, M., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf184 · Cited by 6
Bello, E., Long, K. R., Iwama, S., Steer, J., Cooper, S., Alasoo, K., Kumasaka, N., Schwartzentruber, J., Panousis, N. I., & Bassett, A. R. (2026) · iScience · doi:10.1016/j.isci.2026.115688 · Cited by 7
Thaweerattanasinp, T., Wanitchang, A., Saenboonrueng, J., Srisutthisamphan, K., Wanasen, N., Sungsuwan, S., Jongkaewwattana, A., & Chailangkarn, T. (2023) · PeerJ · doi:10.7717/peerj.14918 · Cited by 6
Jiang, J., Ren, R., Cheng, Y.-J., Li, X., & Zhang, G. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1327466 · Cited by 6
The MIR-NAT MAPT-AS1 does not regulate Tau expression in human neurons
Policarpo, R., Wolfs, L., Martínez‐Montero, S., Vandermeulen, L., Royaux, I. E., Peer, G. V., Mestdagh, P., Sierksma, A. S. R., Strooper, B. D., & d’Ydewalle, C. V. O. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314973 · Cited by 5
Production and Characterization of Human Macrophages from Pluripotent Stem Cells
Lopez‐Yrigoyen, M., May, A., Ventura, T., Taylor, H., Fidanza, A., Cassetta, L., Pollard, J. W., & Forrester, L. M. (2020) · Journal of Visualized Experiments · doi:10.3791/61038-v · Cited by 6
Chen, S., Luo, Z., Ward, C., Ibañez, D. P., Liu, H., Zhong, X., Sharma, N. K., Qin, B., Fan, W., & Wang, D. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101804 · Cited by 6
McVicar, R. N., Smith, E., Melameka, M., Bush, A., Goetz, G., Constantino, G., Kumar, M., Kwong, E. M., Snyder, E. Y., & Leibel, S. L. (2024) · Journal of Visualized Experiments · doi:10.3791/67247 · Cited by 5
Baert, L., Rudy, S., Pellisson, M., Doll, T., Rocchetti, R., Kaiser, M., Mäser, P., & Müller, M. M. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011559 · Cited by 5
Lobato-Moreno, S., Yildiz, U., Claringbould, A., Servaas, N. H., Vlachou, E. P., Arnold, C., Bauersachs, H. G., Campos-Fornés, V., Prummel, K. D., Noh, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.26.573253 · Cited by 5
A critical guideline for controlling monocyte-derived macrophages phenotypes
Moschetti, G., Oliveri, D., Matteis, V. D., Zaccaria, M., Rondelli, D., Griego, A., Scarpa, E., & Rizzello, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694625 · Cited by 5
Armesilla-Diaz, A., Arenaz-Callao, M. P., Ashby, C. A., Blanco, D., D’Oria, E., Garuti, H., Gómez, V., del Río, R. G., Martínez-Hoyos, M., Meiler, E., et al. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01613-24 · Cited by 4
Chrysostomidou, P., Hore, Z. L., Somma, D., Walker, J. M. V., Diallo, K., Titterton, H. F., Elmesmari, A., Schino, L., Adesida, S., Kurowska‐Stolarska, M., et al. (2026) · Brain · doi:10.1093/brain/awag088 · Cited by 4
Fransen, L. F. H., & Leonard, M. O. (2023) · Scientific Reports · doi:10.1038/s41598-023-36508-3 · Cited by 4
Grigor’eva, E. V., Karapetyan, L. V., Malakhova, A. A., Medvedev, S. P., Minina, J. M., Hayrapetyan, V., Vardanyan, V., Zakian, S. M., Arakelyan, A., & Zakharyan, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116102 · Cited by 4
Couch, A. C. M., Brown, A. M., Raimundo, C., Solomon, S., Taylor, M., Sichlinger, L., Matulevičiūtė, R., Srivastava, D. P., & Vernon, A. C. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.007 · Cited by 4
IPSC-derived models in Africa: An HIV perspective
Naidoo, J., Hurrell, T., & Scholefield, J. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.013 · Cited by 4
Funes, S., & Bosco, D. A. (2022) · Journal of Visualized Experiments · doi:10.3791/64323 · Cited by 4
Low basal expression and slow induction of IFITM3 puts immune cells at risk of influenza A infectionPreprint
Wellington, D., Yin, Z., Zhang, L., Forbester, J. L., Kite, K., Laurenson‐Schafer, H., Makvandi‐Nejad, S., Jin, B., Bowes, E., Manoharan, K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.20.885590 · Cited by 4
Armitage, L. H., Maharlooei, M. K., Meacham, A. M., Butfiloski, E. J., Viola, R., Egli, D. M., Sykes, M., Wallet, M. A., & Mathews, C. E. (2021) · SSRN Electronic Journal · doi:10.1101/2021.04.29.441947 · Cited by 5
Bahtiri, S., Hagens, T. M. S., van de Water, B., & Niemeijer, M. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2516051 · Cited by 3
Skeletal Muscle Damage and Inflammation
Washington, T. A., & Schrems, E. R. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_9 · Cited by 5
Mitochondria Clearance Enables Macrophage-Driven Maturation of iPSC-Derived Cardiomyocyte Metabolism
Ketchum, F., Celebi, L. E., Hawthorne, L., & Zorlutuna, P. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00915-z · Cited by 3
Chapleau, A., Perrier, S., Durcan, T. M., & Bernard, G. (2025) · npj Genomic Medicine · doi:10.1038/s41525-025-00533-0 · Cited by 3
De Homdedeu, M., Escribá, R., Rodríguez-González, K., Querol, S., Fernandez-Sojo, J., & Alvarez-Palomo, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1719452 · Cited by 3
Shoda, H., Natsumoto, B., & Fujio, K. (2018) · Immunological Medicine · doi:10.1080/09114300.2018.1451596 · Cited by 3
Cell Reprogramming Techniques: Contributions to Cancer Therapy
Guo, T., & Wei, Q. (2023) · Cellular Reprogramming · doi:10.1089/cell.2023.0011 · Cited by 4
Advances in cellular technology in the hematology field: What have we learned so far?
de Souza, G. T. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.106 · Cited by 3
Modeling the Neurovascular Unit In Vitro and In Silico
Saili, K. S., Zurlinden, T. J., & Knudsen, T. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809405-1.00011-0 · Cited by 3
Automating hESC differentiation with 3D printing and legacy liquid handling solutions
Zluhan, E., Kelly, K., LeClair, N., Wortel, D., & Moody, K. J. (2016) · MethodsX · doi:10.1016/j.mex.2016.10.005 · Cited by 3
Targeting macrophages in liver fibrosis
González del Barrio, L., Ipsen, D. H., Pfister, D. R., Hancz, D., & Scott, C. L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835489 · Cited by 3
Integrating Macrophages into Human-Engineered Cardiac Tissue
Zhao, Y. P., & Fine, B. M. (2025) · Cells · doi:10.3390/cells14171393 · Cited by 2
Paasch, D., Schevel, H., Riehle, A., Costa, B., Toufaili, H., Gehnen, T., Dahlmann, J., Pavlou, A., Neehus, A., Nguyen, A. H. H., et al. (2026) · Clinical & Translational Immunology · doi:10.1002/cti2.70071 · Cited by 2
Chanoumidou, K., Zota, I., Papadopoulou, M. A., Konstantinou, C., Tsimpolis, A., Tsagliotis, E., Tziortziou, M., Ntarntani, K., Grünewald, A., Lavigne, M. D., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-04965-y · Cited by 2
Hayes, K. M., Boldt, K., Schnorr, P. J., Bawa, P., Abyazi, M. L., Ware, M. S., Gyimesi, G., James, M. F., Ko, H., Cunningham‐Rundles, C., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.198703 · Cited by 2
Wu, Y., Wang, Y., Zhang, W., Yuan, L.-L., & Chen, Y. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05080-8 · Cited by 2
Muneekaew, S., Panya, A., Saiprayong, K., Chupradit, K., Nuchphongsai, T., Sasithong, P., Wongpalee, S. P., Boonsatit, N., & Wattanapanitch, M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119609 · Cited by 2
In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
Nikolouli, E., Reichstein, J., Hansen, G., & Lachmann, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1024935 · Cited by 2
Evaluation of the impact of iPSC differentiation protocols on transcriptomic signatures
Chandrasekaran, V., Wellens, S., Bourguignon, A., Djidrovski, I., Fransen, L. F. H., Ghosh, S., Mazidi, Z., Murphy, C., Nunes, C., Singh, P., et al. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105826 · Cited by 3
Peng, D., Li, M., Yu, Z., Yan, T., Meng, Y., Su, L., Liu, Z. H., Li, L., & Qiu, H. (2024) · Cell Proliferation · doi:10.1111/cpr.13770 · Cited by 2
Almatary, A. M., Salem, M. S. H., Elnagar, M. R., Aboutaleb, M. H., Ibrahim, T. S., Hamdi, A., & El‐Sayed, M. A. ‐. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108511 · Cited by 2
Induced pluripotent stem cells to generate skin tissue models
Kashpur, O., Smith, A., Mukhamedshina, N., Baskin, J., Shamis, Y., Hewitt, K. J., Gerami‐Naini, B., & Garlick, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810545-0.00017-6 · Cited by 2
New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
Haake, K., & Lachmann, N. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.11.006 · Cited by 2
Lieberman, R., Elnaggar, K., Jesseman, K., DeFrancisco, S., DeGouveia, K. L., Suneby, E. G., Wu, H., Rojas, L. A., & Graef, J. D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.15.516591 · Cited by 2
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2023) · eLife · doi:10.7554/elife.90695.1 · Cited by 2
Liang, Z., Damianou, A., Vendrell, I., Jenkins, E. M., Lassen, F. H., Washer, S. J., Liu, G., Yi, G., Lou, H., Cao, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.09.561576 · Cited by 2
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2024) · eLife · doi:10.7554/elife.90695.2 · Cited by 2
Sugiyama-Finnis, A., & Yamazaki, S. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.07.001 · Cited by 1
Osgood, J. A., Brown, A., Burnham, K. L., Mielczarek, O., Migliorini, G., Tay, C., Zhang, P., Palmer, M. H., Davies, B. M., Cowley, S. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-18077-9 · Cited by 1
Self-citationhiPSC-Derived Gingival Epithelium-On-Chip for Modeling Inflammation and Immune Response
Zhou, Y., Liu, Y., Lin, X., An, J. Y., & Zhang, M. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c01623 · Cited by 1
Single-nucleus brain transcriptomics reveals microglia dysfunction in multiple system atrophy
Rydbirk, R., Sørensen, F. N. F., Folke, J., Haukedal, H., Asenjo-Martínez, A., Vargas, I. L., McGarry, S., Hollmann, O. C., Gherardelli, C., Sepulveda, S. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71525-6 · Cited by 2
Olschewski, D. N., Koenig, A. M., Nerone, H. M., Groß, E., Šarić, T., Vay, S. U., Schroeter, M., Fink, G. R., & Rueger, M. A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1785992 · Cited by 1
Modeling myeloid cell development in health and disease using induced pluripotent stem cells
Tesakov, I., Nasri, M., Klimiankou, M., Fındık, B., Loskill, P., & Skokowa, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1815809 · Cited by 1
Morrison, R., Mihaylov, S. R., Luk, C. H., Lemerle, C., Rodgers, A., Athanasiadi, N., Morris, H. R., Pellegrino, E., Ultanir, S. K., & Gutierrez, M. G. (2026) · Journal of Cell Science · doi:10.1242/jcs.265083 · Cited by 1
The challenges ahead in immunotoxicity assessment: An in vitro model of human leukopoiesis
Holsapple, M. P., Bach, A. P., Blevins, L. K., Crawford, R. B., Li, J., & Kaminski, N. E. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.06.014 · Cited by 1
Zhao, C., Peng, H., Zhang, R., & Zhang, G. (2017) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-017-0311-8 · Cited by 1
Stem Cells in the Treatment of Diabetic Foot Ulcers
Mir, R., Elfaki, I., Waza, A. A., & Abuduhier, F. M. (2020) · Springer eBooks · doi:10.1007/978-981-15-7639-3_16 · Cited by 1
The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation
Kala, S., Strutz, A. G., & Katt, M. E. (2025) · Neurology International · doi:10.3390/neurolint17010006 · Cited by 2
Lim, Y., Cheong, S. K., & Leong, P. P. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10855-2 · Cited by 1
Trujillo, C. A., Negraes, P. D., Hrvoj-Mihić, B., Lins, M. F. C., Semendeferi, K., & Muotri, A. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00008-1 · Cited by 1
Single-cell reporters for inflammatory caspase activity
Al‐Obeidi, A. (2014) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 1
Toxoplasma -proximal and distal control by GBPs in human macrophagesPreprint
Fisch, D., Clough, B., Khan, R. T., Healy, L. E., & Frickel, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.24.457560 · Cited by 1
Type I interferons govern Zika virus resistance of human macrophages and microgliaPreprint
Hanrath, A. T., Hatton, C. F., Gothe, F., Browne, C., Vowles, J., Leary, P., Cockell, S., Cowley, S. A., James, W., Hambleton, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.09.483671 · Cited by 1
Self-citationSAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammationPreprint
Moore, M. D., Johnson, E., Jacklin, C., Johnson, S., Green, O., & James, W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.25.505278 · Cited by 1
Developmental role of macrophages modelled in human pluripotent stem cell derived intestinal tissuePreprint
Song, A. T., Sindeaux, R., Li, Y., Affia, H., Agnihotri, T., Leclerc, S., Vliet, P. P. V., Colas, M., Guimond, J.-V., Patey, N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.09.505715 · Cited by 1
Morrison, R., Mihaylov, S. R., Luk, C. H., Rodgers, A., Athanasiadi, N., Morris, H. R., Pellegrino, E., Ultanir, S. K., & Gutierrez, M. G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.27.559807 · Cited by 1
Bussi, C., Lai, R., Athanasiade, N., & Gutierrez, M. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.15.585248 · Cited by 1
Albuquerque-Wendt, A., McCoy, C. J., Neish, R., Dobramysl, U., Beneke, T., Cowley, S. A., Crouch, K., Wheeler, R. J., Mottram, J. C., & Gluenz, E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.600025 · Cited by 1
Self-citationDissecting the biological impact of GBA1 mutations using multi-omics in an isogenic settingPreprint
Jerez, P. Á., Crea, P. W., Patel, D., Glasstetter, L. M., Alvarez, C., Makarious, M. B., Lara, E., Chen, Y., Pantazis, C. B., Paquette, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.656971 · Cited by 1
MALDI-TOF mass spectrometry and proteomics as phenotypic screening tools for anti-inflammatory drugsPreprint
Müller, L., Bateman, S., Haslam, C., Dawson, T. K., Vlachou, D. F., Rosa-Roseberry, E., Booty, L. M., Tayler, C. L., Frey, A. M., Annan, R. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.01.691706 · Cited by 1
Control of HIV-1C Replication Both in Vivo and in Vitro
Xie, W. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
HIV-1 evasion of restriction factors: cyclophilin A and cell fusion provide a helping handPreprint
Owen, H., Vaughan-Jackson, A., Nußbaum, L., Vowles, J., James, W., & Moore, M. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/383075
Self-citationA chemical tool for improved culture of human pluripotent stem cellsPreprint
Silpa, L., Schuessler, M., Liu, G., Olivecrona, M., Groizard-Payeras, L., Couper, E., Bataille, C. J. R., Stevenson, M., Seymour, L. W., Davies, S. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.24.918268
Self-citationHuman induced pluripotent stem cells for modeling of Salmonella infection
Forbester, J. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00009-2
Lieberman, R., Gao, G., Hunter, R. B., Leonard, J. P., Cortes, L. K., & Barker, R. H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.16.464657
Theme 03 - IN VITRO EXPERIMENTAL MODELS
(2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1985789
Rujescu, D., & Jung, M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737174478.793578319
Induced pluripotent stem cells
Calvert, B. A., Lorenzana, Z., Senger, C. N., Hsu, C.-Y., Busch, S. M., Koç-Günel, S., Quiroz, E. J., & Ryan, A. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823882-0.00003-5
Kaufman, D. S., & Pouyanfard, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735967778.793563125
Prakash, H. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87474
KillingMycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us
Keiser, T. L., & Purdy, G. E. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch25
Blood components from pluripotent stem cells
Kimbrel, E. A., & Lanza, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00043-5
Lionakis, M. S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727458344.793572027
Metadata
- Authors
- Wilgenburg, B. V., Browne, C., Vowles, J., & Cowley, S. A.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Cowley, Sally A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-12
- Volume
- 8
- Issue
- 8
- Pages
- e71098
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3741356
- OpenAlex
- W2121999038
- Cited by
- 353
- References
- 44
- Citations by year
- 2026: 34 · 2025: 30 · 2024: 50 · 2023: 37 · 2022: 39 · 2021: 36 · 2020: 35 · 2019: 19 · 2018: 27 · 2017: 18 · 2016: 13 · 2015: 10 · 2014: 3 · 2013: 2
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust (91070, WT082260, G090074791070, G0900747, LC0910-004, 090532, 090532/Z/09/Z, 090532/Z/09/, 090532/Z)
- Parkinson's UK (J-0901)
- Medical Research Council (G0900747 91070, Hub grant G0900747 91070, 090532/Z09/Z)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- monocyte-derived macrophages, human pluripotent stem cells, human embryonic stem cells, human induced pluripotent stem cells, defined culture conditions, serum-free culture, HIV-1 infection, lentiviral transduction, transgene expression, macrophage phagocytosis, inflammatory cytokines, macrophage infection model
- MeSH terms
- Cell Differentiation, Cell Line, Culture Media, Gene Expression Regulation, Humans, Macrophages, Monocytes, Phagocytosis, Phenotype, HIV-1, Macrophage Colony-Stimulating Factor, Cell Culture Techniques, Polymorphism, Single Nucleotide, Pluripotent Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
